Caspase cleavage of HER-2 releases a Bad-like cell death effector.

Abstract

Human epidermal growth factor receptor-2 (HER-2/ErbB2/neu), a receptor tyrosine kinase that is amplified/overexpressed in poor prognosis breast carcinomas, confers resistance to apoptosis by activating cell survival pathways. Here we demonstrate that the cytoplasmic tail of HER-2 is cleaved by caspases at Asp(1016)/Asp(1019) to release a approximately 47-kDa product, which is subsequently proteolyzed by caspases at Asp(1125) into an unstable 22-kDa fragment that is degraded by the proteasome and a predicted 25-kDa product. Both the 47- and 25-kDa products translocate to mitochondria, release cytochrome c by a Bcl-x(L)-suppressible mechanism, and induce caspase-dependent apoptosis. The 47- and 25-kDa HER-2 cleavage products share a functional BH3-like domain, which is required for cytochrome c release in cells and isolated mitochondria and for apoptosis induction. Caspase-cleaved HER-2 binds Bcl-x(L) and acts synergistically with truncated Bid to induce apoptosis, mimicking the actions of the BH3-only protein Bad. Moreover, the HER-2 cleavage products cooperate with Noxa to induce apoptosis in cells expressing both Bcl-x(L) and Mcl-1, confirming their Bad-like function. Collectively, our results indicate that caspases activate a previously unrecognized proapoptotic function of HER-2 by releasing a Bad-like cell death effector.

DOI: 10.1074/jbc.M802156200

Statistics

02004002008200920102011201220132014201520162017
Citations per Year

682 Citations

Semantic Scholar estimates that this publication has 682 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Strohecker2008CaspaseCO, title={Caspase cleavage of HER-2 releases a Bad-like cell death effector.}, author={Anne M. Strohecker and Fruma Yehiely and Feng Chen and Vincent L Cryns}, journal={The Journal of biological chemistry}, year={2008}, volume={283 26}, pages={18269-82} }